Literature DB >> 12699033

Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions.

Jonathan S Abramowitz1, Edna B Foa, Martin E Franklin.   

Abstract

Exposure and ritual prevention (ERP) is the most effective treatment for obsessive-compulsive disorder (OCD), yet the intensive treatment schedule often described is not transportable to many settings. In the present study, the authors examined whether a twice-weekly (TW) ERP program reduced the effectiveness of intensive (IT) ERP. Forty OCD patients received 15 sessions of ERP: 20 received daily treatment over 3 weeks and 20 received twice weekly therapy over 8 weeks. Results indicated that both programs were effective. The effect of therapy schedule was moderate, with a trend toward more improvement in the intensive group at posttreatment. No differences were found at follow-up; some evidence of relapse was found with IT but not TW.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699033     DOI: 10.1037/0022-006x.71.2.394

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  36 in total

1.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

2.  Stepped care for obsessive-compulsive disorder: An open trial.

Authors:  Christina M Gilliam; Gretchen J Diefenbach; Sara E Whiting; David F Tolin
Journal:  Behav Res Ther       Date:  2010-07-30

3.  Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Jonathan D Huppert; Shawn Cahill; Michael J Maher; Carmen P McLean; James Bender; Sue M Marcus; Monnica T Williams; Jamie Weaver; Donna Vermes; Page E Van Meter; Carolyn I Rodriguez; Mark Powers; Anthony Pinto; Patricia Imms; Chang-Gyu Hahn; Raphael Campeas
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

4.  Intensive Family-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder: Applications for Treatment of Medication Partial- or Nonresponders.

Authors:  Wendi E Marien; Eric A Storch; Gary R Geffken; Tanya K Murphy
Journal:  Cogn Behav Pract       Date:  2009-08

Review 5.  Psychotherapy for obsessive-compulsive disorder.

Authors:  Eric A Storch; Amy Mariaskin; Tanya K Murphy
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

6.  The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.

Authors:  Monnica T Williams; Samantha G Farris; Eric N Turkheimer; Martin E Franklin; H Blair Simpson; Michael Liebowitz; Edna B Foa
Journal:  J Anxiety Disord       Date:  2014-06-14

7.  Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial.

Authors:  Edna B Foa; Carmen P McLean; Yinyin Zang; David Rosenfield; Elna Yadin; Jeffrey S Yarvis; Jim Mintz; Stacey Young-McCaughan; Elisa V Borah; Katherine A Dondanville; Brooke A Fina; Brittany N Hall-Clark; Tracey Lichner; Brett T Litz; John Roache; Edward C Wright; Alan L Peterson
Journal:  JAMA       Date:  2018-01-23       Impact factor: 56.272

Review 8.  Cognitive behavioral therapy for obsessive-compulsive disorder: an update.

Authors:  Jonathan D Huppert; Martin E Franklin
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

9.  Intensive cognitive therapy for PTSD: a feasibility study.

Authors:  Anke Ehlers; David M Clark; Ann Hackmann; Nick Grey; Sheena Liness; Jennifer Wild; John Manley; Louise Waddington; Freda McManus
Journal:  Behav Cogn Psychother       Date:  2010-07

Review 10.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.